| Year |
Citation |
Score |
| 2020 |
Chen M, Liang S, Shahid A, Andresen BT, Huang Y. The β-Blocker Carvedilol Prevented Ultraviolet-Mediated Damage of Murine Epidermal Cells and 3D Human Reconstructed Skin. International Journal of Molecular Sciences. 21. PMID 31991834 DOI: 10.3390/Ijms21030798 |
0.371 |
|
| 2019 |
Cleveland KH, Liang S, Chang A, Huang KM, Chen S, Guo L, Huang Y, Andresen BT. Carvedilol inhibits EGF-mediated JB6 P+ colony formation through a mechanism independent of adrenoceptors. Plos One. 14: e0217038. PMID 31107911 DOI: 10.1371/Journal.Pone.0217038 |
0.343 |
|
| 2018 |
Cleveland KH, Yeung S, Huang KM, Liang S, Andresen BT, Huang Y. Phosphoproteome profiling provides insight into the mechanism of action for carvedilol-mediated cancer prevention. Molecular Carcinogenesis. PMID 29626349 DOI: 10.1002/Mc.22820 |
0.429 |
|
| 2017 |
Huang KM, Liang S, Yeung S, Oiyemhonlan E, Cleveland KH, Parsa C, Orlando R, Meyskens FL, Andresen BT, Huang Y. Topically Applied Carvedilol Attenuates Solar Ultraviolet Radiation Induced Skin Carcinogenesis. Cancer Prevention Research (Philadelphia, Pa.). PMID 28912118 DOI: 10.1158/1940-6207.Capr-17-0132 |
0.317 |
|
| 2016 |
Huang KM, Cleveland KH, Yeung S, Andresen BT, Huang Y. Abstract 2617: Protective effect of the β-blocker carvedilol on UVB-induced skin damage Cancer Research. 76: 2617-2617. DOI: 10.1158/1538-7445.Am2016-2617 |
0.369 |
|
| 2015 |
Chang A, Yeung S, Thakkar A, Huang KM, Liu MM, Kanassatega RS, Parsa C, Orlando R, Jackson EK, Andresen BT, Huang Y. Prevention of skin carcinogenesis by the β-blocker carvedilol. Cancer Prevention Research (Philadelphia, Pa.). 8: 27-36. PMID 25367979 DOI: 10.1158/1940-6207.Capr-14-0193 |
0.386 |
|
| 2015 |
Huang KM, Chang A, Cleveland KH, Andresen BT, Huang Y. Abstract 1915: Effects of carvedilol, a β-adrenergic receptor antagonist, on UVB-induced skin cancer development and its possible mechanism of action Cancer Research. 75: 1915-1915. DOI: 10.1158/1538-7445.Am2015-1915 |
0.389 |
|
| 2014 |
Hao J, Lee R, Chang A, Fan J, Labib C, Parsa C, Orlando R, Andresen B, Huang Y. DMH1, a small molecule inhibitor of BMP type i receptors, suppresses growth and invasion of lung cancer. Plos One. 9: e90748. PMID 24603907 DOI: 10.1371/Journal.Pone.0090748 |
0.367 |
|
| 2014 |
Liu M, Ravula R, Wang Z, Zuo Z, Chow MS, Thakkar A, Prabhu S, Andresen B, Huang Y. Traditional Chinese medicinal formula Si-Wu-Tang prevents oxidative damage by activating Nrf2-mediated detoxifying/antioxidant genes. Cell & Bioscience. 4: 8. PMID 24507416 DOI: 10.1186/2045-3701-4-8 |
0.353 |
|
| 2014 |
Huang Y, Lee R, Chang A, Fan J, Labib C, Parsa C, Orlando R, Andresen B, Hao J. Abstract 2717: DMH1, a small molecule inhibitor of BMP type I receptors, suppresses growth and invasion of lung cancer Cancer Research. 74: 2717-2717. DOI: 10.1158/1538-7445.Am2014-2717 |
0.399 |
|
| 2014 |
Chang A, Liu M, Yeung S, Hao J, Parsa C, Orlando R, Andresen B, Huang Y. Abstract 1256: The chemopreventive effects of carvedilol on skin carcinogenesis Cancer Research. 74: 1256-1256. DOI: 10.1158/1538-7445.Am2014-1256 |
0.323 |
|
| 2013 |
Erickson CE, Gul R, Blessing CP, Nguyen J, Liu T, Pulakat L, Bastepe M, Jackson EK, Andresen BT. The β-blocker Nebivolol Is a GRK/β-arrestin biased agonist. Plos One. 8: e71980. PMID 23977191 DOI: 10.1371/Journal.Pone.0071980 |
0.338 |
|
| 2013 |
Nistala R, Andresen BT, Pulakat L, Meuth A, Sinak C, Mandavia C, Thekkumkara T, Speth RC, Whaley-Connell A, Sowers JR. Angiotensin type 1 receptor resistance to blockade in the opossum proximal tubule cell due to variations in the binding pocket. American Journal of Physiology. Renal Physiology. 304: F1105-13. PMID 23389452 DOI: 10.1152/Ajprenal.00127.2012 |
0.421 |
|
| 2011 |
Andresen BT. A pharmacological primer of biased agonism. Endocrine, Metabolic & Immune Disorders Drug Targets. 11: 92-8. PMID 21476970 DOI: 10.2174/187153011795564179 |
0.342 |
|
| 2010 |
Andresen BT. Characterization of G protein-coupled receptor kinase 4 and measuring its constitutive activity in vivo. Methods in Enzymology. 484: 631-51. PMID 21036254 DOI: 10.1016/B978-0-12-381298-8.00031-9 |
0.471 |
|
| 2008 |
DeMarco VG, Habibi J, Whaley-Connell AT, Schneider RI, Heller RL, Bosanquet JP, Hayden MR, Delcour K, Cooper SA, Andresen BT, Sowers JR, Dellsperger KC. Oxidative stress contributes to pulmonary hypertension in the transgenic (mRen2)27 rat. American Journal of Physiology. Heart and Circulatory Physiology. 294: H2659-68. PMID 18424632 DOI: 10.1152/Ajpheart.00953.2007 |
0.338 |
|
| 2008 |
Keever LB, Jones JE, Andresen BT. G protein-coupled receptor kinase 4gamma interacts with inactive Galpha(s) and Galpha13. Biochemical and Biophysical Research Communications. 367: 649-55. PMID 18190783 DOI: 10.1016/J.Bbrc.2007.12.181 |
0.388 |
|
| 2008 |
Whaley-Connell A, Habibi J, Nistala R, Cooper SA, Karuparthi PR, Hayden MR, Rehmer N, Demarco VG, Andresen BT, Wei Y, Ferrario C, Sowers JR. Attenuation of NADPH oxidase activation and glomerular filtration barrier remodeling with statin treatment Hypertension. 51: 474-480. PMID 18172055 DOI: 10.1161/Hypertensionaha.107.102467 |
0.376 |
|
| 2008 |
Escano CS, Keever LB, Gutweiler AA, Andresen BT. Angiotensin II activates extracellular signal-regulated kinase independently of receptor tyrosine kinases in renal smooth muscle cells: implications for blood pressure regulation. The Journal of Pharmacology and Experimental Therapeutics. 324: 34-42. PMID 17911376 DOI: 10.1124/Jpet.107.126300 |
0.509 |
|
| 2008 |
Chen X, Andresen BT, Hill M, Zhang J, Booth F, Zhang C. Role of reactive oxygen species in tumor necrosis factor-alpha induced endothelial dysfunction Current Hypertension Reviews. 4: 245-255. DOI: 10.2174/157340208786241336 |
0.32 |
|
| 2005 |
Jackson EK, Andresen BT, Seasholtz TM, Zhu C, Romero GG. Enhanced activation of RhoA by angiotensin II in SHR preglomerular microvascular smooth muscle cells. Journal of Cardiovascular Pharmacology. 45: 283-5. PMID 15772513 DOI: 10.1097/01.Fjc.0000155383.83927.9F |
0.639 |
|
| 2005 |
Andresen BT, Shome K, Jackson EK, Romero GG. AT2 receptors cross talk with AT1 receptors through a nitric oxide- and RhoA-dependent mechanism resulting in decreased phospholipase D activity. American Journal of Physiology. Renal Physiology. 288: F763-70. PMID 15572519 DOI: 10.1152/Ajprenal.00323.2004 |
0.68 |
|
| 2004 |
Andresen BT, Romero GG, Jackson EK. AT2 receptors attenuate AT1 receptor-induced phospholipase D activation in vascular smooth muscle cells. The Journal of Pharmacology and Experimental Therapeutics. 309: 425-31. PMID 14722318 DOI: 10.1124/Jpet.103.061846 |
0.647 |
|
| 2003 |
Andresen BT, Linnoila JJ, Jackson EK, Romero GG. Role of EGFR transactivation in angiotensin II signaling to extracellular regulated kinase in preglomerular smooth muscle cells. Hypertension. 41: 781-6. PMID 12623996 DOI: 10.1161/01.Hyp.0000049426.61176.Df |
0.647 |
|
| 2002 |
Andresen BT, Rizzo MA, Shome K, Romero G. The role of phosphatidic acid in the regulation of the Ras/MEK/Erk signaling cascade. Febs Letters. 531: 65-8. PMID 12401205 DOI: 10.1016/S0014-5793(02)03483-X |
0.655 |
|
| 2001 |
Andresen BT, Jackson EK, Romero GG. Angiotensin II signaling to phospholipase D in renal microvascular smooth muscle cells in SHR. Hypertension. 37: 635-9. PMID 11230348 DOI: 10.1161/01.Hyp.37.2.635 |
0.66 |
|
| 2000 |
Shome K, Rizzo MA, Vasudevan C, Andresen B, Romero G. The activation of phospholipase D by endothelin-1, angiotensin II, and platelet-derived growth factor in vascular smooth muscle A10 cells is mediated by small G proteins of the ADP-ribosylation factor family. Endocrinology. 141: 2200-8. PMID 10830309 DOI: 10.1210/Endo.141.6.7517 |
0.69 |
|
| 2000 |
Andresen BT, Jackson EK, Romero GG. Angiotensin II Signals to Phospholipase D in the Spontaneously Hypertensive and Wistar-Kyoto Rats by Pharmacologically Distinct Mechanisms Hypertension. 36: 722-723. DOI: 10.1161/01.Hyp.36.Suppl_1.722 |
0.662 |
|
| Show low-probability matches. |